UB Paderborn / Katalog / Suche / in CDI

Tuberculosis following PD-1 blockade for cancer immunotherapy

Science translational medicine, 2019-01, Vol.11 (475)

2019

Link zum Volltext

Verfügbarkeit prüfen

Safety and immunogenicity of a thermostable ID93 + GLA-SE tuberculosis vaccine candidate in healthy adults

Nature communications, 2023-03, Vol.14 (1), p.1138-1138, Article 1138

2023

Link zum Volltext

Verfügbarkeit prüfen

Antibodies inhibit prion propagation and clear cell cultures of prion infectivity

Nature (London), 2001-08, Vol.412 (6848), p.739-743

2001

Link zum Volltext

Verfügbarkeit prüfen

Inactivation of Prions by Acidic Sodium Dodecyl Sulfate

Journal of Virology, 2006-01, Vol.80 (1), p.322-331

2006

Link zum Volltext

Verfügbarkeit prüfen

A Change in the Conformation of Prions Accompanies the Emergence of a New Prion Strain

Neuron (Cambridge, Mass.), 2002-06, Vol.34 (6), p.921-932

2002

Link zum Volltext

Verfügbarkeit prüfen

Measuring prions causing bovine spongiform encephalopathy or chronic wasting disease by immunoassays and transgenic mice

Nature biotechnology, 2002-11, Vol.20 (11), p.1147-1150

2002

Link zum Volltext

Verfügbarkeit prüfen

Dominant-Negative Inhibition of Prion Replication in Transgenic Mice

Proceedings of the National Academy of Sciences - PNAS, 2002-10, Vol.99 (20), p.13079-13084

2002

Link zum Volltext

Verfügbarkeit prüfen

A defined subunit vaccine that protects against vector-borne visceral leishmaniasis

npj vaccines, 2017-08, Vol.2 (1), p.23-23, Article 23

2017

Link zum Volltext

Verfügbarkeit prüfen

Safety and immunogenicity of the novel tuberculosis vaccine ID93 + GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase 1 trial

The lancet respiratory medicine, 2018-04, Vol.6 (4), p.287-298

2018

Link zum Volltext

Verfügbarkeit prüfen

A phase 1 antigen dose escalation trial to evaluate safety, tolerability and immunogenicity of the leprosy vaccine candidate LepVax (LEP-F1 + GLA–SE) in healthy adults

Vaccine, 2020-02, Vol.38 (7), p.1700-1707

2020

Link zum Volltext

Verfügbarkeit prüfen

The TLR-4 agonist adjuvant, GLA-SE, improves magnitude and quality of immune responses elicited by the ID93 tuberculosis vaccine: first-in-human trial

npj vaccines, 2018-09, Vol.3 (1), p.34-34, Article 34

2018

Link zum Volltext

Verfügbarkeit prüfen

Safety and immunogenicity of the adjunct therapeutic vaccine ID93 + GLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo-controlled, phase 2a trial

The lancet respiratory medicine, 2021-04, Vol.9 (4), p.373-386

2021

Link zum Volltext

Verfügbarkeit prüfen

Strategic evaluation of vaccine candidate antigens for the prevention of Visceral Leishmaniasis

Vaccine, 2016-05, Vol.34 (25), p.2779-2786

2016

Link zum Volltext

Verfügbarkeit prüfen

A nanoliposome delivery system to synergistically trigger TLR4 AND TLR7

Journal of nanobiotechnology, 2014-04, Vol.12 (1), p.17-17, Article 17

2014

Link zum Volltext

Verfügbarkeit prüfen

From mouse to man: safety, immunogenicity and efficacy of a candidate leishmaniasis vaccine LEISH‐F3+GLA‐SE

Clinical & translational immunology, 2015-04, Vol.4 (4), p.e35-n/a

2015

Link zum Volltext

Verfügbarkeit prüfen

TLR4 ligand formulation causes distinct effects on antigen-specific cell-mediated and humoral immune responses

Vaccine, 2013-12, Vol.31 (49), p.5848-5855

2013

Link zum Volltext

Verfügbarkeit prüfen

A structure‐function approach to optimizing TLR4 ligands for human vaccines

Clinical & translational immunology, 2016-11, Vol.5 (11), p.e108-n/a

2016

Link zum Volltext

Verfügbarkeit prüfen

Optimizing manufacturing and composition of a TLR4 nanosuspension: physicochemical stability and vaccine adjuvant activity

Journal of nanobiotechnology, 2013-12, Vol.11 (1), p.43-43, Article 43

2013

Link zum Volltext

Verfügbarkeit prüfen

From mouse to man: safety, immunogenicity and efficacy of a candidate leishmaniasis vaccine LEISH-F3+GLA-SE

Clinical & translational immunology, 2015-04, Vol.4 (4), p.e35

2015

Link zum Volltext

Verfügbarkeit prüfen

Giardia muris trophozoite antigenic targets for mouse intestinal IgA antibody

The Journal of infectious diseases, 1994-02, Vol.169 (2), p.395

1994

Link zum Volltext

Verfügbarkeit prüfen

Just-in-Time Training for the Use of ICU Nurse Extenders During COVID-19 Pandemic Response

Military medicine, 2021-09, Vol.186 (Supplement_2), p.40-43

2021

Link zum Volltext

Verfügbarkeit prüfen

Relationship between prenatal antibiotic use and asthma in at-risk children

Annals of allergy, asthma, & immunology, 2015-03, Vol.114 (3), p.203-207

2015

Link zum Volltext

Verfügbarkeit prüfen

The Clustering of Submillimeter Galaxies Detected with ALMA

The Astrophysical journal, 2020-11, Vol.904 (1), p.2

2020

Link zum Volltext

Verfügbarkeit prüfen

Characterization of Nipah virus infection in a model of human airway epithelial cells cultured at an air-liquid interface

Journal of general virology, 2016-05, Vol.97 (5), p.1077-1086

2016

Link zum Volltext

Verfügbarkeit prüfen

Networking our science to characterize the state, vulnerabilities, and management opportunities of soil organic matter

Global change biology, 2018-02, Vol.24 (2), p.e705-e718

2018

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Tuberculosis following PD-1 blockade for cancer immunotherapy

Safety and immunogenicity of a thermostable ID93 + GLA-SE tuberculosis vaccine candidate in healthy adults

Antibodies inhibit prion propagation and clear cell cultures of prion infectivity

Inactivation of Prions by Acidic Sodium Dodecyl Sulfate

A Change in the Conformation of Prions Accompanies the Emergence of a New Prion Strain

Measuring prions causing bovine spongiform encephalopathy or chronic wasting disease by immunoassays and transgenic mice

Dominant-Negative Inhibition of Prion Replication in Transgenic Mice

A defined subunit vaccine that protects against vector-borne visceral leishmaniasis

Safety and immunogenicity of the novel tuberculosis vaccine ID93 + GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase 1 trial

A phase 1 antigen dose escalation trial to evaluate safety, tolerability and immunogenicity of the leprosy vaccine candidate LepVax (LEP-F1 + GLA–SE) in healthy adults

The TLR-4 agonist adjuvant, GLA-SE, improves magnitude and quality of immune responses elicited by the ID93 tuberculosis vaccine: first-in-human trial

Safety and immunogenicity of the adjunct therapeutic vaccine ID93 + GLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo-controlled, phase 2a trial

Strategic evaluation of vaccine candidate antigens for the prevention of Visceral Leishmaniasis

A nanoliposome delivery system to synergistically trigger TLR4 AND TLR7

From mouse to man: safety, immunogenicity and efficacy of a candidate leishmaniasis vaccine LEISH‐F3+GLA‐SE

TLR4 ligand formulation causes distinct effects on antigen-specific cell-mediated and humoral immune responses

A structure‐function approach to optimizing TLR4 ligands for human vaccines

Optimizing manufacturing and composition of a TLR4 nanosuspension: physicochemical stability and vaccine adjuvant activity

From mouse to man: safety, immunogenicity and efficacy of a candidate leishmaniasis vaccine LEISH-F3+GLA-SE

Giardia muris trophozoite antigenic targets for mouse intestinal IgA antibody

Just-in-Time Training for the Use of ICU Nurse Extenders During COVID-19 Pandemic Response

Relationship between prenatal antibiotic use and asthma in at-risk children

The Clustering of Submillimeter Galaxies Detected with ALMA

Characterization of Nipah virus infection in a model of human airway epithelial cells cultured at an air-liquid interface

Networking our science to characterize the state, vulnerabilities, and management opportunities of soil organic matter

Suchergebnisse filtern